nigrostriatal pathway

E804590

The nigrostriatal pathway is a major dopaminergic tract in the brain that connects the substantia nigra to the striatum and is crucial for the control of movement, with degeneration in this pathway underlying Parkinson’s disease.

Jump to: Statements Referenced by

Statements (49)

Predicate Object
instanceOf dopaminergic pathway
neural pathway
affectedBy MPTP neurotoxin
neuroleptic drugs
typical antipsychotics
associatedWithDisease Huntington's disease NERFINISHED
Parkinson's disease NERFINISHED
drug-induced parkinsonism
multiple system atrophy NERFINISHED
progressive supranuclear palsy NERFINISHED
belongsTo central nervous system
connectsFrom substantia nigra pars compacta
connectsTo caudate nucleus NERFINISHED
putamen
striatum
degenerationLeadsTo akinesia
bradykinesia
gait disturbance
postural instability
resting tremor
rigidity
discoveredInContextOf basal ganglia research
hasAxonTerminalLocation caudate nucleus NERFINISHED
dorsal striatum
putamen NERFINISHED
hasCellBodyLocation substantia nigra pars compacta NERFINISHED
hasDirection efferent projection from midbrain to forebrain
hasFunction control of voluntary movement
modulation of habit learning
modulation of procedural learning
regulation of motor planning
regulation of movement execution
regulation of movement initiation
hasNeurotransmitter dopamine
involvesReceptor dopamine D1 receptor NERFINISHED
dopamine D2 receptor NERFINISHED
dopamine D3 receptor NERFINISHED
dopamine D4 receptor
dopamine D5 receptor NERFINISHED
isMajor dopaminergic tract in the brain
locatedIn brain
partOf basal ganglia circuitry
extrapyramidal motor system
projectsTo medium spiny neurons of the striatum
targetOf COMT inhibitors
L-DOPA therapy
MAO-B inhibitors
dopamine agonists
usesNeurotransmitter dopamine

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

substantia nigra suppliesDopamineTo nigrostriatal pathway